We recently identified a family with lattice corneal dystrophy type IIIA (LCD IIIA) associated with a novel threonine-to-proline (T621P) mutation in the transforming growth factor-beta induced (TGFBI) gene.
The safety of laser surgery in LCD is yet to be established. 1 There are reports that LCD recurs after phototherapeutic keratectomy.
2 TGFBI-related LCD IIIA might be exacerbated after refractive surgery according to reports on the exacerbation of different TGFBIrelated corneal dystrophies after LASIK or LASEK. 3, 4 Furthermore, Weissman and Randleman 5 showed that interface abnormalities occurring in granular corneal dystrophy after LASIK were improved after therapeutic amputation of the flap.
Gene tests are currently being applied to screen out common TGFBI mutations before refractive surgery. Young patients (eg, III-1, III-2, and III-4) of an affected family can be detected only when the whole TGFBI gene is sequenced. Because the whole gene sequence cannot routinely be obtained from young patients with clear corneas, it is important for the surgeon to obtain an accurate history of vision in the family before deciding to proceed with corneal refractive surgery. 
